glp 1 ra Generic Liraglutide Approved, Marking First Generic GLP-1 Indicated Specifically for Weight Management in the US 🔸 Should GLP-1 RAs be

Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons

The FDA has declined approval for Biogen's higher-dose application of Spinraza (nusinersen), a critical treatment for spinal muscular atrophy (SMA)

Given the divergent outcomes of these studies, the efficacies of GLP-1R agonists for opioid-related responses need to be investigated in greater detail

[DOI] [PubMed] [Google Scholar] 204.Knudsen L.B., Pridal L

Whilst generally well-tolerated, like all medications, GLP-1 agonists carry potential side effects that patients and healthcare professionals should understand, including concerns about pancreatic safety that warrant careful consideration